Delayed Generic Market Saturation After Patent Expiration-A Billion-Dollar Problem

JAMA Intern Med. 2018 May 1;178(5):721-722. doi: 10.1001/jamainternmed.2018.0989.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Atorvastatin
  • Drugs, Generic*
  • Economic Competition
  • Health Expenditures*

Substances

  • Drugs, Generic
  • Atorvastatin